We’re ScreenPoint Medical

Decision support that truly supports

We’re ScreenPoint Medical

We are bringing AI to the fight against breast cancer with leading clinical evidence and the latest deep learning technology.

Untitled

Improve patient outcomes

Every day, we work with radiologists in clinical practice and research to continually improve the proven deep learning algorithms in Transpara®. Our goal? Give women and their providers confidence in screening mammography.

Untitled

Deep learning from the start

Because not all AI is the same, our origins matter to your results. ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection.

See why users trust Transpara

In the decade since its founding, ScreenPoint and its flagship product Transpara have helped thousands of radiologists and supported care for millions of women with a relentless focus on improving workflow, increasing confidence and delivering clinically and operationally relevant results. That’s why users trust Transpara.

Improve patient outcomes

Our partners, your workflow

At ScreenPoint, we know that breast imaging – and particularly breast screening – cannot function without effective workflow. To support our customers, we have designed an offering that is flexible and environment agnostic. Transpara works on 2D and 3D acquisitions, and our detection algorithm works on gantries from every major manufacturer. Regardless of your workflow, we want to fit seamlessly into your toolkit, so we work hard to ensure a seamless integration regardless of acquisition and reading environments.

Our Leadership

Executive leadership

Mark Koeniguer

CEO

Joined SPM in 2022 International industry executive with extensive experience scaling and growing transformational companies. Recently, he helped scale Volpara Health resulting in its IPO on ASX, and also led R2 Technologies to a successful exit. Mark started his career at GE Healthcare where he held various leadership roles.

Nico Karssemeijer

CSO

Founded SPM in 2014 oProfessor in Radiology at Radboud University (#4 in best global radiology department ranking) and CEO until 2022. Pioneer in development of computer aided detection and 30+ years experience in breast imaging. Consulted for R2 Technology and Hologic. Co-founder of Volpara Healthcare Ltd. and Qview Medical Inc.

Pieter Kroese

COO

Joined SPM in 2018 Pieter has a strong general and financial management background. Next to corporate environments, he also has experience as a founder of a startup and mainly worked in international settings. Pieter led the initial commercialization of ScreenPoint, including establishment of the US team.

Executive Board

Sir Michael Brady

Co-Founder and Chairman Supervisory Board

Professor Sir Michael Brady FRS FMedSci FREng is a world leading scientist in computer vision, robotics, and medical image analysis. He co-authored Mammographic Image Analysis (Kluwer 1999) with Ralph Highnam; the ideas introduced in this monograph – together with some later innovative developments by Nico Karssemeijer and colleagues – provided the basis for Volpara density. […]

Renate Rohde

Supervisory Board Member

Renate is the Senior Vice President Finance for X-ray Products within Siemens Healthineers. In that capacity, she serves as board member and observer in several Joint Ventures and VC investments, including Non-executive Director at ScreenPoint Medical. Renate has extensive international experience in financial management. In previous roles, she covered a broad range of finance leadership […]

Allyson White

Supervisory Board Member

Allyson joined Insight in 2012. Previously, she was a strategy consultant in the markets and customers practice at Monitor Group, where she advised multi-national companies on growth strategy, product innovation, acquisitions, scenario planning and pricing strategy. She worked in a variety of industries including Pharmaceutical, Insurance, and Chemicals. Allyson graduated with high honors from the […]

Dr Rachel Brem

Supervisory Board Member

Dr. Rachel Brem is the Director of Breast Imaging and Intervention at The George Washington University Medical Center, Professor of Radiology and the Vice Chairman of the Department of Radiology. In 2015 Dr. Brem was named the Program Leader for Breast Cancer at the GW Cancer Center. Dr. Brem completed her undergraduate studies at Brandeis […]

Medical Advisory Board

Jennifer Harvey MD

Medical Advisory Board

Jennifer Harvey is Professor and Chair at the University of Rochester Department of Imaging Sciences. Harvey is an international expert in breast imaging and the early detection of breast cancer. Previously, she was on faculty at the University of Virginia for 26 years, leading its Division of Breast Imaging, Breast Cancer Program, and serving as […]

Laurie Margolies MD

Medical Advisory Board

Laurie Margolies, MD, Director of Breast Imaging at Mount Sinai Health System, an American College of Radiology fellow and past-President of the New York Breast Imaging Society. Margolies received her medical degree from Yale School of Medicine and has been in practice for more than 20 years. Her research interests include health care disparities, breast […]

Dr Ritse Mann

Medical Advisory Board

Dr. Ritse Mann is a breast and interventional radiologist at the Radboud University Medical Center in Nijmegen and the Netherlands Cancer Institute in Amsterdam and is leading clinical breast imaging research at both institutions. His areas of interest include breast cancer screening, breast MRI, minimal invasive therapy and the use of artificial intelligence for screening, […]

Follow Us